Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $8.44M in the quarter ending September 30, 2024, with 41.59% growth. This brings the company's revenue in the last twelve months to $32.96M, up 61.94% year-over-year. In the year 2023, Sunshine Biopharma had annual revenue of $24.09M with 454.42% growth.

• Revenue (ttm): $32.96M
• Revenue Growth: +61.94%
• P/S Ratio: 0.01
• Revenue / Employee: $749,079
• Employees: 44
• Market Cap: 5.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	24.09M	19.75M	454.42%
Dec 31, 2022	4.35M	4.12M	1,802.41%
Dec 31, 2021	228.43K	157.02K	219.88%
Dec 31, 2020	71.41K	50.29K	238.10%
Dec 31, 2019	21.12K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.